OUE Healthcare Limited said on Apr, 24 2026 that three independent and non-executive directors—Roger Tan Chade Phang, Eric Sho Kian Hin and Jackson Tay Eng Kiat—retired at the close of the company’s annual general meeting after reaching the nine-year tenure limit set by the Singapore Exchange Catalist Rules.

Following their departure, the company appointed independent director Usha Ranee Chandradas as chair of the Nominating and Remuneration Committee, while non-independent director Abram Melkyzedeck Suhardiman joined the Audit and Risk Committee.

With these changes, the board now comprises non-executive chairman Lee Yi Shyan, chief executive officer and executive director Yet Kum Meng, non-independent director Abram Melkyzedeck Suhardiman, and independent director Usha Ranee Chandradas. The Nominating and Remuneration Committee consists of Usha Ranee Chandradas (chair) and Lee Yi Shyan, while the Audit and Risk Committee includes Usha Ranee Chandradas and Abram Melkyzedeck Suhardiman.

OUE Healthcare said it has begun searching for additional independent and non-executive directors and aims to fill the vacancies within two months, or no later than three months, to remain compliant with Catalist Rule 704(7).